Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Ventilator Associated Pneumonia (VAP) Revenue 1.4 Market Analysis by Type 1.4.1 Global Ventilator Associated Pneumonia (VAP) Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Prevention 1.4.3 Physiotherapy 1.4.4 Immunity Therapy 1.5 Market by Application 1.5.1 Global Ventilator Associated Pneumonia (VAP) Market Share by Application: 2020 VS 2026 1.5.2 Hospitals 1.5.3 ASCs 1.5.4 Diagnostic Centers 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Ventilator Associated Pneumonia (VAP) Market Perspective (2015-2026) 2.2 Ventilator Associated Pneumonia (VAP) Growth Trends by Regions 2.2.1 Ventilator Associated Pneumonia (VAP) Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Ventilator Associated Pneumonia (VAP) Historic Market Share by Regions (2015-2020) 2.2.3 Ventilator Associated Pneumonia (VAP) Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Ventilator Associated Pneumonia (VAP) Market Growth Strategy 2.3.6 Primary Interviews with Key Ventilator Associated Pneumonia (VAP) Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Ventilator Associated Pneumonia (VAP) Players by Market Size 3.1.1 Global Top Ventilator Associated Pneumonia (VAP) Players by Revenue (2015-2020) 3.1.2 Global Ventilator Associated Pneumonia (VAP) Revenue Market Share by Players (2015-2020) 3.1.3 Global Ventilator Associated Pneumonia (VAP) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Ventilator Associated Pneumonia (VAP) Market Concentration Ratio 3.2.1 Global Ventilator Associated Pneumonia (VAP) Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Ventilator Associated Pneumonia (VAP) Revenue in 2019 3.3 Ventilator Associated Pneumonia (VAP) Key Players Head office and Area Served 3.4 Key Players Ventilator Associated Pneumonia (VAP) Product Solution and Service 3.5 Date of Enter into Ventilator Associated Pneumonia (VAP) Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Ventilator Associated Pneumonia (VAP) Historic Market Size by Type (2015-2020) 4.2 Global Ventilator Associated Pneumonia (VAP) Forecasted Market Size by Type (2021-2026) 5 Ventilator Associated Pneumonia (VAP) Breakdown Data by Application (2015-2026) 5.1 Global Ventilator Associated Pneumonia (VAP) Market Size by Application (2015-2020) 5.2 Global Ventilator Associated Pneumonia (VAP) Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Ventilator Associated Pneumonia (VAP) Market Size (2015-2020) 6.2 Ventilator Associated Pneumonia (VAP) Key Players in North America (2019-2020) 6.3 North America Ventilator Associated Pneumonia (VAP) Market Size by Type (2015-2020) 6.4 North America Ventilator Associated Pneumonia (VAP) Market Size by Application (2015-2020) 7 Europe 7.1 Europe Ventilator Associated Pneumonia (VAP) Market Size (2015-2020) 7.2 Ventilator Associated Pneumonia (VAP) Key Players in Europe (2019-2020) 7.3 Europe Ventilator Associated Pneumonia (VAP) Market Size by Type (2015-2020) 7.4 Europe Ventilator Associated Pneumonia (VAP) Market Size by Application (2015-2020) 8 China 8.1 China Ventilator Associated Pneumonia (VAP) Market Size (2015-2020) 8.2 Ventilator Associated Pneumonia (VAP) Key Players in China (2019-2020) 8.3 China Ventilator Associated Pneumonia (VAP) Market Size by Type (2015-2020) 8.4 China Ventilator Associated Pneumonia (VAP) Market Size by Application (2015-2020) 9 Japan 9.1 Japan Ventilator Associated Pneumonia (VAP) Market Size (2015-2020) 9.2 Ventilator Associated Pneumonia (VAP) Key Players in Japan (2019-2020) 9.3 Japan Ventilator Associated Pneumonia (VAP) Market Size by Type (2015-2020) 9.4 Japan Ventilator Associated Pneumonia (VAP) Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Ventilator Associated Pneumonia (VAP) Market Size (2015-2020) 10.2 Ventilator Associated Pneumonia (VAP) Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Ventilator Associated Pneumonia (VAP) Market Size by Type (2015-2020) 10.4 Southeast Asia Ventilator Associated Pneumonia (VAP) Market Size by Application (2015-2020) 11 India 11.1 India Ventilator Associated Pneumonia (VAP) Market Size (2015-2020) 11.2 Ventilator Associated Pneumonia (VAP) Key Players in India (2019-2020) 11.3 India Ventilator Associated Pneumonia (VAP) Market Size by Type (2015-2020) 11.4 India Ventilator Associated Pneumonia (VAP) Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Ventilator Associated Pneumonia (VAP) Market Size (2015-2020) 12.2 Ventilator Associated Pneumonia (VAP) Key Players in Central & South America (2019-2020) 12.3 Central & South America Ventilator Associated Pneumonia (VAP) Market Size by Type (2015-2020) 12.4 Central & South America Ventilator Associated Pneumonia (VAP) Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Philips Respironics 13.1.1 Philips Respironics Company Details 13.1.2 Philips Respironics Business Overview and Its Total Revenue 13.1.3 Philips Respironics Ventilator Associated Pneumonia (VAP) Introduction 13.1.4 Philips Respironics Revenue in Ventilator Associated Pneumonia (VAP) Business (2015-2020)) 13.1.5 Philips Respironics Recent Development 13.2 Hoffrichter 13.2.1 Hoffrichter Company Details 13.2.2 Hoffrichter Business Overview and Its Total Revenue 13.2.3 Hoffrichter Ventilator Associated Pneumonia (VAP) Introduction 13.2.4 Hoffrichter Revenue in Ventilator Associated Pneumonia (VAP) Business (2015-2020) 13.2.5 Hoffrichter Recent Development 13.3 Johnson Controls 13.3.1 Johnson Controls Company Details 13.3.2 Johnson Controls Business Overview and Its Total Revenue 13.3.3 Johnson Controls Ventilator Associated Pneumonia (VAP) Introduction 13.3.4 Johnson Controls Revenue in Ventilator Associated Pneumonia (VAP) Business (2015-2020) 13.3.5 Johnson Controls Recent Development 13.4 Teleflex 13.4.1 Teleflex Company Details 13.4.2 Teleflex Business Overview and Its Total Revenue 13.4.3 Teleflex Ventilator Associated Pneumonia (VAP) Introduction 13.4.4 Teleflex Revenue in Ventilator Associated Pneumonia (VAP) Business (2015-2020) 13.4.5 Teleflex Recent Development 13.5 Weinmann 13.5.1 Weinmann Company Details 13.5.2 Weinmann Business Overview and Its Total Revenue 13.5.3 Weinmann Ventilator Associated Pneumonia (VAP) Introduction 13.5.4 Weinmann Revenue in Ventilator Associated Pneumonia (VAP) Business (2015-2020) 13.5.5 Weinmann Recent Development 13.6 ResMed 13.6.1 ResMed Company Details 13.6.2 ResMed Business Overview and Its Total Revenue 13.6.3 ResMed Ventilator Associated Pneumonia (VAP) Introduction 13.6.4 ResMed Revenue in Ventilator Associated Pneumonia (VAP) Business (2015-2020) 13.6.5 ResMed Recent Development 13.7 SYSMED 13.7.1 SYSMED Company Details 13.7.2 SYSMED Business Overview and Its Total Revenue 13.7.3 SYSMED Ventilator Associated Pneumonia (VAP) Introduction 13.7.4 SYSMED Revenue in Ventilator Associated Pneumonia (VAP) Business (2015-2020) 13.7.5 SYSMED Recent Development 13.8 Fisher & Paykel 13.8.1 Fisher & Paykel Company Details 13.8.2 Fisher & Paykel Business Overview and Its Total Revenue 13.8.3 Fisher & Paykel Ventilator Associated Pneumonia (VAP) Introduction 13.8.4 Fisher & Paykel Revenue in Ventilator Associated Pneumonia (VAP) Business (2015-2020) 13.8.5 Fisher & Paykel Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Ventilator Associated Pneumonia (VAP) Key Market Segments Table 2. Key Players Covered: Ranking by Ventilator Associated Pneumonia (VAP) Revenue Table 3. Ranking of Global Top Ventilator Associated Pneumonia (VAP) Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Ventilator Associated Pneumonia (VAP) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Prevention Table 6. Key Players of Physiotherapy Table 7. Key Players of Immunity Therapy Table 8. Global Ventilator Associated Pneumonia (VAP) Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 9. Global Ventilator Associated Pneumonia (VAP) Market Size by Regions (US$ Million): 2020 VS 2026 Table 10. Global Ventilator Associated Pneumonia (VAP) Market Size by Regions (2015-2020) (US$ Million) Table 11. Global Ventilator Associated Pneumonia (VAP) Market Share by Regions (2015-2020) Table 12. Global Ventilator Associated Pneumonia (VAP) Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 13. Global Ventilator Associated Pneumonia (VAP) Market Share by Regions (2021-2026) Table 14. Market Top Trends Table 15. Key Drivers: Impact Analysis Table 16. Key Challenges Table 17. Ventilator Associated Pneumonia (VAP) Market Growth Strategy Table 18. Main Points Interviewed from Key Ventilator Associated Pneumonia (VAP) Players Table 19. Global Ventilator Associated Pneumonia (VAP) Revenue by Players (2015-2020) (Million US$) Table 20. Global Ventilator Associated Pneumonia (VAP) Market Share by Players (2015-2020) Table 21. Global Top Ventilator Associated Pneumonia (VAP) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ventilator Associated Pneumonia (VAP) as of 2019) Table 22. Global Ventilator Associated Pneumonia (VAP) by Players Market Concentration Ratio (CR5 and HHI) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Ventilator Associated Pneumonia (VAP) Product Solution and Service Table 25. Date of Enter into Ventilator Associated Pneumonia (VAP) Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Ventilator Associated Pneumonia (VAP) Market Size by Type (2015-2020) (Million US$) Table 28. Global Ventilator Associated Pneumonia (VAP) Market Size Share by Type (2015-2020) Table 29. Global Ventilator Associated Pneumonia (VAP) Revenue Market Share by Type (2021-2026) Table 30. Global Ventilator Associated Pneumonia (VAP) Market Size Share by Application (2015-2020) Table 31. Global Ventilator Associated Pneumonia (VAP) Market Size by Application (2015-2020) (Million US$) Table 32. Global Ventilator Associated Pneumonia (VAP) Market Size Share by Application (2021-2026) Table 33. North America Key Players Ventilator Associated Pneumonia (VAP) Revenue (2019-2020) (Million US$) Table 34. North America Key Players Ventilator Associated Pneumonia (VAP) Market Share (2019-2020) Table 35. North America Ventilator Associated Pneumonia (VAP) Market Size by Type (2015-2020) (Million US$) Table 36. North America Ventilator Associated Pneumonia (VAP) Market Share by Type (2015-2020) Table 37. North America Ventilator Associated Pneumonia (VAP) Market Size by Application (2015-2020) (Million US$) Table 38. North America Ventilator Associated Pneumonia (VAP) Market Share by Application (2015-2020) Table 39. Europe Key Players Ventilator Associated Pneumonia (VAP) Revenue (2019-2020) (Million US$) Table 40. Europe Key Players Ventilator Associated Pneumonia (VAP) Market Share (2019-2020) Table 41. Europe Ventilator Associated Pneumonia (VAP) Market Size by Type (2015-2020) (Million US$) Table 42. Europe Ventilator Associated Pneumonia (VAP) Market Share by Type (2015-2020) Table 43. Europe Ventilator Associated Pneumonia (VAP) Market Size by Application (2015-2020) (Million US$) Table 44. Europe Ventilator Associated Pneumonia (VAP) Market Share by Application (2015-2020) Table 45. China Key Players Ventilator Associated Pneumonia (VAP) Revenue (2019-2020) (Million US$) Table 46. China Key Players Ventilator Associated Pneumonia (VAP) Market Share (2019-2020) Table 47. China Ventilator Associated Pneumonia (VAP) Market Size by Type (2015-2020) (Million US$) Table 48. China Ventilator Associated Pneumonia (VAP) Market Share by Type (2015-2020) Table 49. China Ventilator Associated Pneumonia (VAP) Market Size by Application (2015-2020) (Million US$) Table 50. China Ventilator Associated Pneumonia (VAP) Market Share by Application (2015-2020) Table 51. Japan Key Players Ventilator Associated Pneumonia (VAP) Revenue (2019-2020) (Million US$) Table 52. Japan Key Players Ventilator Associated Pneumonia (VAP) Market Share (2019-2020) Table 53. Japan Ventilator Associated Pneumonia (VAP) Market Size by Type (2015-2020) (Million US$) Table 54. Japan Ventilator Associated Pneumonia (VAP) Market Share by Type (2015-2020) Table 55. Japan Ventilator Associated Pneumonia (VAP) Market Size by Application (2015-2020) (Million US$) Table 56. Japan Ventilator Associated Pneumonia (VAP) Market Share by Application (2015-2020) Table 57. Southeast Asia Key Players Ventilator Associated Pneumonia (VAP) Revenue (2019-2020) (Million US$) Table 58. Southeast Asia Key Players Ventilator Associated Pneumonia (VAP) Market Share (2019-2020) Table 59. Southeast Asia Ventilator Associated Pneumonia (VAP) Market Size by Type (2015-2020) (Million US$) Table 60. Southeast Asia Ventilator Associated Pneumonia (VAP) Market Share by Type (2015-2020) Table 61. Southeast Asia Ventilator Associated Pneumonia (VAP) Market Size by Application (2015-2020) (Million US$) Table 62. Southeast Asia Ventilator Associated Pneumonia (VAP) Market Share by Application (2015-2020) Table 63. India Key Players Ventilator Associated Pneumonia (VAP) Revenue (2019-2020) (Million US$) Table 64. India Key Players Ventilator Associated Pneumonia (VAP) Market Share (2019-2020) Table 65. India Ventilator Associated Pneumonia (VAP) Market Size by Type (2015-2020) (Million US$) Table 66. India Ventilator Associated Pneumonia (VAP) Market Share by Type (2015-2020) Table 67. India Ventilator Associated Pneumonia (VAP) Market Size by Application (2015-2020) (Million US$) Table 68. India Ventilator Associated Pneumonia (VAP) Market Share by Application (2015-2020) Table 69. Central & South America Key Players Ventilator Associated Pneumonia (VAP) Revenue (2019-2020) (Million US$) Table 70. Central & South America Key Players Ventilator Associated Pneumonia (VAP) Market Share (2019-2020) Table 71. Central & South America Ventilator Associated Pneumonia (VAP) Market Size by Type (2015-2020) (Million US$) Table 72. Central & South America Ventilator Associated Pneumonia (VAP) Market Share by Type (2015-2020) Table 73. Central & South America Ventilator Associated Pneumonia (VAP) Market Size by Application (2015-2020) (Million US$) Table 74. Central & South America Ventilator Associated Pneumonia (VAP) Market Share by Application (2015-2020) Table 75. Philips Respironics Company Details Table 76. Philips Respironics Business Overview Table 77. Philips Respironics Product Table 78. Philips Respironics Revenue in Ventilator Associated Pneumonia (VAP) Business (2015-2020) (Million US$) Table 79. Philips Respironics Recent Development Table 80. Hoffrichter Company Details Table 81. Hoffrichter Business Overview Table 82. Hoffrichter Product Table 83. Hoffrichter Revenue in Ventilator Associated Pneumonia (VAP) Business (2015-2020) (Million US$) Table 84. Hoffrichter Recent Development Table 85. Johnson Controls Company Details Table 86. Johnson Controls Business Overview Table 87. Johnson Controls Product Table 88. Johnson Controls Revenue in Ventilator Associated Pneumonia (VAP) Business (2015-2020) (Million US$) Table 89. Johnson Controls Recent Development Table 90. Teleflex Company Details Table 91. Teleflex Business Overview Table 92. Teleflex Product Table 93. Teleflex Revenue in Ventilator Associated Pneumonia (VAP) Business (2015-2020) (Million US$) Table 94. Teleflex Recent Development Table 95. Weinmann Company Details Table 96. Weinmann Business Overview Table 97. Weinmann Product Table 98. Weinmann Revenue in Ventilator Associated Pneumonia (VAP) Business (2015-2020) (Million US$) Table 99. Weinmann Recent Development Table 100. ResMed Company Details Table 101. ResMed Business Overview Table 102. ResMed Product Table 103. ResMed Revenue in Ventilator Associated Pneumonia (VAP) Business (2015-2020) (Million US$) Table 104. ResMed Recent Development Table 105. SYSMED Company Details Table 106. SYSMED Business Overview Table 107. SYSMED Product Table 108. SYSMED Revenue in Ventilator Associated Pneumonia (VAP) Business (2015-2020) (Million US$) Table 109. SYSMED Recent Development Table 110. Fisher & Paykel Business Overview Table 111. Fisher & Paykel Product Table 112. Fisher & Paykel Company Details Table 113. Fisher & Paykel Revenue in Ventilator Associated Pneumonia (VAP) Business (2015-2020) (Million US$) Table 114. Fisher & Paykel Recent Development Table 115. Research Programs/Design for This Report Table 116. Key Data Information from Secondary Sources Table 117. Key Data Information from Primary Sources List of Figures Figure 1. Global Ventilator Associated Pneumonia (VAP) Market Share by Type: 2020 VS 2026 Figure 2. Prevention Features Figure 3. Physiotherapy Features Figure 4. Immunity Therapy Features Figure 5. Global Ventilator Associated Pneumonia (VAP) Market Share by Application: 2020 VS 2026 Figure 6. Hospitals Case Studies Figure 7. ASCs Case Studies Figure 8. Diagnostic Centers Case Studies Figure 9. Ventilator Associated Pneumonia (VAP) Report Years Considered Figure 10. Global Ventilator Associated Pneumonia (VAP) Market Size YoY Growth 2015-2026 (US$ Million) Figure 11. Global Ventilator Associated Pneumonia (VAP) Market Share by Regions: 2020 VS 2026 Figure 12. Global Ventilator Associated Pneumonia (VAP) Market Share by Regions (2021-2026) Figure 13. Porter's Five Forces Analysis Figure 14. Global Ventilator Associated Pneumonia (VAP) Market Share by Players in 2019 Figure 15. Global Top Ventilator Associated Pneumonia (VAP) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ventilator Associated Pneumonia (VAP) as of 2019 Figure 16. The Top 10 and 5 Players Market Share by Ventilator Associated Pneumonia (VAP) Revenue in 2019 Figure 17. North America Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2015-2020) (Million US$) Figure 18. Europe Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2015-2020) (Million US$) Figure 19. China Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Japan Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Southeast Asia Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2015-2020) (Million US$) Figure 22. India Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Central & South America Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Philips Respironics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 25. Philips Respironics Revenue Growth Rate in Ventilator Associated Pneumonia (VAP) Business (2015-2020) Figure 26. Hoffrichter Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. Hoffrichter Revenue Growth Rate in Ventilator Associated Pneumonia (VAP) Business (2015-2020) Figure 28. Johnson Controls Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. Johnson Controls Revenue Growth Rate in Ventilator Associated Pneumonia (VAP) Business (2015-2020) Figure 30. Teleflex Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. Teleflex Revenue Growth Rate in Ventilator Associated Pneumonia (VAP) Business (2015-2020) Figure 32. Weinmann Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. Weinmann Revenue Growth Rate in Ventilator Associated Pneumonia (VAP) Business (2015-2020) Figure 34. ResMed Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. ResMed Revenue Growth Rate in Ventilator Associated Pneumonia (VAP) Business (2015-2020) Figure 36. SYSMED Total Revenue (US$ Million): 2019 Compared with 2018 Figure 37. SYSMED Revenue Growth Rate in Ventilator Associated Pneumonia (VAP) Business (2015-2020) Figure 38. Fisher & Paykel Total Revenue (US$ Million): 2019 Compared with 2018 Figure 39. Fisher & Paykel Revenue Growth Rate in Ventilator Associated Pneumonia (VAP) Business (2015-2020) Figure 40. Bottom-up and Top-down Approaches for This Report Figure 41. Data Triangulation Figure 42. Key Executives Interviewed

Philips Respironics Hoffrichter Johnson Controls Teleflex Weinmann ResMed SYSMED Fisher & Paykel